Midi Health review

What I actually think of Midi Health

Midi Health is the strangest scorecard I have filled in. On price transparency it is the best provider on this entire site — it publishes every dose and what that dose costs, on a public page, before you give it your name. On what getting started costs your week, no provider here asks more. Both of those things are true, and which one matters more depends entirely on whether you can get to a scheduled appointment.

This is a midlife women's clinic that treats weight as one lane inside perimenopause care, not a weight-loss shop with a hormone add-on. Its own help centre calls it "a virtual clinic that provides specialty care for women 35+". If you are 34 and postpartum, that framing is not aimed at you. If you are 44 and the weight arrived at the same time as the night sweats, it might be the only provider on my list that treats those as the same problem.

A pricing page that shames the rest

Midi publishes a table. An actual table, at /glp1-pricing, headed "Transparent Pricing. No membership fees. No surprises." Compounded injectable GLP-1 runs $165.90 at the starting doses, $270.90 in the middle, $340 higher up and $355 at the top. The dual-action GLP-1/GIP ladder runs $210 to $434. There are sublingual versions of both, from $164 and $209. Shipping and supplies are in those numbers. There is no membership fee, and none appears later.

I want to be honest about what that table also shows you, though, because it is the thing a monthly budget cares about: your bill more than doubles as you titrate. Semaglutide goes from $165.90 to $355 for the same four weeks of medicine. A flat-price compounder holds the number steady while your dose climbs; Midi does not, and it tells you so up front instead of letting you discover it in month four. Disclosed is much better than hidden. It is still the difference between $166 and $355.

And there is a second bill. The visit is not in the medication price. Insured, you pay your normal copay — Midi says it is in-network with most PPO plans, which is genuinely rare here. Self-pay, it is $250 for the first visit and $150 for each one after. So a first month, self-pay, at a starting dose, is about $416, not $165.90. Price it that way from the beginning and you will not be blindsided.

One figure I could not make add up: the weight page advertises microdosing at "Weekly doses start at $34 for eligible patients." I could not reconcile $34 a week against any row in the published table, and I would rather tell you that than quietly convert it into a monthly number that nobody at Midi has actually quoted.

Where I hit the wall, and what is behind it

I walked the public funnel and it stopped me fast. "Book a Visit" does not open a quiz or a price screen — it opens a full account-creation form asking for first and last name, email, phone, date of birth, sex assigned at birth, and your complete street address. That is where I stopped, because everything past it needs a real account and I do not make those.

Here is what Midi publishes about the rest, so you know before you fill that form in. You complete a health questionnaire at least 24 hours before your appointment. You reply YES to a confirmation text or the slot is released to someone else. Then you meet a clinician on video for about 30 minutes, somewhere quiet and private, with your camera and audio tested — and Midi will not see you while you are driving. Cancel or move it with less than 24 hours' notice and there is a fee, the amount of which is not published anywhere I could find.

Read that list again as a mother of small children. A day-early questionnaire, a mandatory text reply, thirty minutes on camera in a quiet room. No other provider on my list asks that much of your calendar before it will write anything, and it is why the number at the top of this page sits where it does. It is not a knock on the medicine or the clinicians. It is a knock on the calendar.

The thing nobody names

The price table never says semaglutide or tirzepatide. It says "GLP-1 Injectable" and "Dual-Action GLP-1/GIP Injectable" and prices them by milligram. The dose ladders give it away — 0.1 to 2.5 mg is the semaglutide range, 1.25 to 15 mg is the tirzepatide one — but a company that has gone to the trouble of publishing every price could name the drug in the vial. With any compounded product, ask your clinician to name both the molecule and the pharmacy that fills it. Midi also prescribes brand-name GLP-1s to a pharmacy of your choosing, which it does not price at all.

Who it is for, and who it is not

It is for a woman in midlife with a PPO plan, who wants a clinician relationship rather than a form, and who can hold a scheduled half-hour. If perimenopause is part of what changed, that framing is worth real money. It is not for you if you are on Medicaid or Medi-Cal — Midi says it cannot treat those patients "even as self-pay" — or if the appointment is the exact barrier that has kept you stuck. And the standing rule holds here as everywhere: no GLP-1 is established as safe in pregnancy or breastfeeding, and every label advises against it. That is a conversation for after weaning, with your own clinician.

So, would I use it?

If my insurance covered the visit and my life had a reliable thirty minutes in it, yes — I would take Midi's honesty about money over a cheaper vial from a company that will not tell me what anything costs. It does not, and mine does not, which is why for most moms I would still start with CoreAge Rx, where the price is flat and the intake fits in a nap. You can see the two side by side in this head-to-head, and if the appointment is your blocker, the no-video-visit board is the faster read.